Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the Endothelin(A) Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial

Anand, I., McMurray, J. , Cohn, J., Konstam, M., Notter, T., Quitzau, K., Ruschitzka, F., Luscher, T. and Investigators, E. (2004) Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the Endothelin(A) Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial. Lancet, 364, pp. 347-354.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McMurray, Professor John
Authors: Anand, I., McMurray, J., Cohn, J., Konstam, M., Notter, T., Quitzau, K., Ruschitzka, F., Luscher, T., and Investigators, E.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences
Journal Name:Lancet

University Staff: Request a correction | Enlighten Editors: Update this record